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Abstract
Purpose: The Japan Society of Obstetrics and Gynecology (JSOG) implemented an 
assisted reproductive technology (ART) registry system in 1986. Here are reported the 
characteristics and treatment outcomes of ART cycles that were registered in 2015.
Methods: JSOG has requested all participating ART facilities to register cycle- specific 
information for all ART cycles since 2007. A descriptive analysis was performed by 
using the registry database for 2015.
Results: In total, 424 151 cycles and 51 001 neonates (1 in 19.7 neonates born in 
Japan) were registered in 2015. The patients’ mean age was 38.2 years (standard de-
viation = 4.5). Among the fresh cycles, 94 158 of 244 718 (38.5%) egg retrieval cycles 
were cycles with freeze- all embryos or oocytes, while fresh embryo transfer (ET) was 
performed in 70 254 cycles, signaling a decrease from 2014. There were 169 898 
frozen- thawed ET cycles, resulting in 56 355 pregnancies and 40 599 neonates. Single 
ET was performed at a rate of 79.7% for fresh and 81.8% for frozen cycles and the 
singleton pregnancy/live birth rates were 96.9%/96.5% and 96.8%/96.4% for the re-
spective cycles.
Conclusion: The total ART cycles and live births resulting from ART has been increas-
ing in Japan. Single ET was performed at a rate of almost 80% and ET cycles have 
shifted from fresh to frozen cycles.
K E Y W O R D S
assisted reproductive technology, in vitro fertilization, intracytoplasmic sperm injection, single 
embryo transfer, The Japan Society of Obstetrics and Gynecology
1  | INTRODUCTION
Since the first baby was born as a result of in vitro fertilization (IVF) 
in the UK in 1978,1 assisted reproductive technology (ART) has been 
used as infertility treatment globally. More than 1 million babies 
worldwide were reportedly born as a result of ART between 2008 
and 2010.2 In Japan, the first baby born after IVF was reported by 
Tohoku University in 1983.3 Since then, the number of ART cycles has 
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increased dramatically and Japan has reportedly become one of the 
largest contributors of ART worldwide in terms of the annual number 
of procedures done.2
In order to record the characteristics and clinical outcomes of ART 
that are implemented in Japan, The Japan Society of Obstetrics and 
Gynecology (JSOG), Tokyo, Japan, developed an ART registry system in 
1986. In 2007, JSOG launched an online registration system to collect 
cycle- specific information for all ART treatment cycles. Here are re-
ported the characteristics and treatment outcomes of the ART cycles 
that were performed between 1 January and 31 December, 2015.
2  | MATERIALS AND METHODS
Since 2007, JSOG has requested that all ART clinics and hospitals 
register cycle- specific information for all ART cycles, including pa-
tient characteristics, information on ART treatment, and pregnancy 
and obstetric outcomes. Details on the information that has been 
collected in the registry have been reported previously.4 For the pe-
riod from 1 January to 31 December, 2015, JSOG requested that 
information on each treatment cycle that was performed at all par-
ticipating institutions be registered via an online registry system 
by the end of November, 2016. This study was approved by the 
Institutional Review Board at the National Center for Child Health 
and Development, Tokyo, Japan, and the Ethical Review Board at 
JSOG.
Using the ART registry database in 2015, a descriptive analysis was 
performed to investigate the characteristics and treatment outcomes 
of registered fresh and frozen cycles. The number of registered cycles, 
egg retrievals, embryo transfer (ET) cycles, fresh cycles with freeze- all 
embryos or oocytes, pregnancies, and neonates was compared with 
that in previous years. The characteristics of the registered cycles and 
treatment outcomes were described for the fresh and the frozen cy-
cles. The treatment outcomes included the pregnancy, miscarriage, 
and live birth rates, multiple pregnancies, and pregnancy outcomes 
for an ectopic pregnancy, intrauterine pregnancy coexisting with an 
ectopic pregnancy, artificial abortion, stillbirth, and fetal reduction. 
Furthermore, the treatment outcomes of pregnancy and the live birth 
and miscarriage rates were analyzed by patient age finally; the treat-
ment outcomes for frozen- thawed ET using frozen- thawed oocytes 
also were investigated.
3  | RESULTS
There were 607 registered ART facilities in 2015, of which 603 par-
ticipated in the ART registration system. The number of facilities that 
actually provided information on cycle- specific information for ART 
treatment in 2015 was 574; the number of implemented cycles was 
zero at 29 facilities. The trends in the number of registered cycles, egg 
retrievals, pregnancies, and neonates for IVF, intracytoplasmic sperm 
injection (ICSI), and frozen- thawed ET cycles from 1985 to 2015 are 
shown in Table1. In 2015, 424 151 cycles were registered and 51 001 
neonates, accounting for 1 in 19.7 neonates who were born in Japan, 
were recorded. The total number of registered cycles showed an in-
creasing trend from 1985 to 2015 for both fresh and frozen cycles. 
In 2015, the number of cycles that was registered for fresh IVF, fresh 
ICSI, and frozen cycles was 93 614, 155 797, and 174 740, respec-
tively. The total number of fresh cycles with freeze- all embryos or 
oocytes showed an increasing trend both for IVF and ICSI cycles and 
30 498 IVF (32.6%) and 63 660 ICSI (40.9%) cycles were cycles with 
freeze- all embryos or oocytes in 2015, resulting in fewer fresh ET 
cycles in 2015 than in 2014. In terms of frozen cycles, 171 495 fro-
zen ETs were performed, resulting in 56 888 pregnancies and 40 611 
births in 2015.
The age distribution of the women who were treated with ART in 
2015 is shown in Figure 1. The patients’ mean age for the registered 
cycles was 38.2 years (standard deviation [SD] = 4.5), while the mean 
age for pregnancy and live birth cycles was 36.2 years (SD = 4.1) and 
35.7 years (SD = 4.0), respectively.
The characteristics and treatment outcomes of the registered 
fresh cycles are shown in Table2. There were 89 780 registered 
IVF cycles, 22 860 split ICSI cycles, 130 132 ICSI cycles using ejac-
ulated sperm, 2803 ICSI cycles using testicular sperm  extraction 
(TESE), 50 gamete intrafallopian transfer (GIFT) cycles, 374 cycles 
with oocyte freezing based on medical indications, and 3410 other 
F IGURE  1 Age distribution of the 
registered cycles, cycles with embryo 
transfer, pregnancies, and live births in 
Japan in 2015, according to the Assisted 
Reproductive Technology registry. 
Adapted from The Japan Society of 
Obstetrics and Gynecology ART Databook 
2015 (http://plaza.umin.ac.jp/~jsog-
art/2015data_201709.pdf) (in Japanese)
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cycles. Single ET was performed at a rate of 79.7%. The pregnancy 
rate per ET was 22.6% for IVF, 24.4% for split ICSI, 18.9% for ICSI 
using ejaculated sperm, 16.7% for ICSI with TESE, and 10.3% for 
GIFT. The miscarriage rate per pregnancy was 26.0% for IVF, 21.6% 
for split ICSI, 28.7% for ICSI using ejaculated sperm, and 32.5% for 
ICSI with TESE, resulting in the respective live birth rate per ET of 
15.7%, 18.0%, 12.8%, and 10.5%, respectively. The singleton preg-
nancy rate and live birth rate were 96.9% and 96.5%, respectively.
The characteristics and treatment outcomes of the frozen  cycles 
are shown in Table3. There were 172 946 registered frozen- thawed 
TABLE  2 Characteristics and treatment outcomes of the registered fresh cycles using assisted reproductive technology in Japan in 2015
Variable IVF- ET Split ICSI
ICSI
GIFT
Oocyte 
freezing Othersa
Ejaculated 
sperm TESE Total
No. of registered cycles 89 780 22 862 130 132 2803 50 374 3410 249 411
No. of egg retrievals 87 425 22 679 128 160 2800 50 366 3238 244 718
No. of fresh ET cycles 28 388 6597 33 807 992 39 0 431 70 254
No. of cycles with freeze- all embryos or 
oocytes
29 541 13 173 49 291 1196 4 312 641 94 158
No. of cycles with a pregnancy 6403 1609 6394 166 4 — 71 14 647
Pregnancy rate per ET 22.6% 24.4% 18.9% 16.7% 10.3% — 16.5% 20.8%
Pregnancy rate per egg retrieval 7.3% 7.1% 5.0% 5.9% 8.0% — 2.2% 6.0%
Pregnancy rate per egg retrieval  excluding 
cycles with freeze- all embryos
11.1% 16.9% 8.1% 10.3% 8.7% — 2.7% 9.7%
SET cycles 22 947 5677 26 457 573 9 — 308 55 971
Pregnancy following SET cycles 5234 1414 5054 105 0 — 57 11 864
Rate of SET cycles 80.8% 86.1% 78.3% 57.8% 23.1% — 71.5% 79.7%
Pregnancy rate following SET 22.8% 24.9% 19.1% 18.3% 0.0% — 18.5% 21.2%
Miscarriages 1666 348 1838 54 3 — 16 3925
Miscarriage rate per pregnancy 26.0% 21.6% 28.7% 32.5% 75.0% — 22.5% 26.8%
Singleton pregnanciesb 6003 1536 5991 142 3 — 69 13 744
Multiple pregnanciesb 190 40 200 8 1 — 1 440
Twin pregnanciesb 186 40 198 8 1 — 1 434
Triplet pregnanciesb 3 0 2 0 0 — 0 5
Quadruplet pregnanciesb 1 0 0 0 0 — 0 1
Multiple pregnancy rate 3.1% 2.5% 3.2% 5.3% 25.0% — 1.4% 3.1%
Live births 4448 1185 4316 104 1 — 51 10 105
Live birth rate per ET 15.7% 18.0% 12.8% 10.5% 2.6% — 11.8% 14.4%
Total number of neonates 4577 1220 4432 109 1 — 51 10 390
Singleton live births 4285 1147 4167 99 1 — 51 9750
Twin live births 143 35 131 5 0 — 0 314
Triplet live births 2 1 1 0 0 — 0 4
Quadruplet live births 1 0 0 0 0 — 0 1
Pregnancy outcomes
Ectopic pregnancies 103 24 70 2 0 — 1 200
Intrauterine pregnancies coexisting with 
an ectopic pregnancy
0 0 1 0 0 — 0 1
Artificial abortions 15 6 26 0 0 — 1 48
Stillbirths 25 10 22 1 0 — 2 60
Fetal reductions 6 0 1 0 0 — 0 7
Unknown cycles for pregnancy outcomes 112 24 89 4 0 — 0 229
a”Others” includes zygote intrafallopian transfer; bSingleton, twin, triplet, and quadruplet pregnancies were defined according to the number of gestational 
sacs in utero. ET, embryo transfer; GIFT, gamete intrafallopian transfer; ICSI, intracytoplasmic sperm injection; IVF- ET, in vitro fertilization- embryo transfer; 
SET, single embryo transfer; TESE, testicular sperm extraction.
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ET cycles, of which 169 898 were performed and from which 
56 355 pregnancies resulted (the pregnancy rate per frozen- thawed 
ET = 33.2%). The miscarriage rate per pregnancy was 26.4%, resulting 
in a 23.0% live birth rate per ET. Single ET was performed at a rate of 
81.8% and the singleton pregnancy rate was 96.8%. Among the live 
births, 96.4% were singletons.
The total number of registered ET cycles, the number and rate of 
pregnancies, and the rate of live births and miscarriages by patient 
age in 2015 are shown in Table4. The distribution of the pregnancy, 
live birth, and miscarriage rates for each age is shown in Figure2. 
The pregnancy rate per ET exceeded 40% up to 32 years of age and 
gradually fell below 30% after 39 years of age and below 10% after 
44 years of age. The miscarriage rate per pregnancy was 17% for 
those who were under 32 years of age and it gradually increased with 
an increase in patient age. The miscarriage rate was 34.6% for those 
who were 40 years of age and 52.4% for those who were 43 years of 
age. The live birth rate per registered cycle was ~20% up to 33 years 
of age and it decreased to 9.1% by 40 years of age and 3.0% by 
43 years of age.
The treatment outcomes for ET using frozen- thawed oocytes are 
shown in Table 5. The total number of ETs using frozen oocytes was 
135 cycles, of which 15 cycles resulted in a pregnancy (the pregnancy 
rate per ET = 11.1%). The miscarriage rate per pregnancy was 26.7%, 
resulting in an 8.1% live birth rate per ET.
4  | DISCUSSION
Using the ART registry system, this study demonstrated that the total 
number of registered ART cycles (424 151 cycles) and resultant live 
births (51 001 neonates, or 1 in 19.7 neonates who were born in Japan) 
were largest in 2015. Single ET was performed at a rate of almost 80% 
for both fresh and frozen cycles, resulting in a singleton live birth rate 
of 96%. The number of fresh cycles with freeze- all embryos or oocytes 
increased, resulting in a reduction in the number of fresh ET cycles. 
These results represent the latest clinical practice of ART in Japan.
One of the reasons for the increasing number of ART cycles is the 
age of the patients who are receiving ART. In the registered cycles, 
the mean age of the patients was 38.2 years (SD = 4.5) and the mean 
age for the cycles with live births was 35.7 years (SD = 4.0). Both fig-
ures were very high, compared with the mean age of Japanese women 
who have given birth. According to a 2015 report from the Ministry of 
Health, Labour and Welfare, the mean maternal age at the time of the 
first birth is 30.7 years.5 Maternal age was the most important factor 
to determine the probability of a live birth after ART. As the pregnancy 
and live birth rates decreased as the maternal age increased (Table 4), 
the number of ET cycles resulting in a live birth theoretically would 
exceed that in mothers of a younger age.
Single ET was performed at a rate of almost 80%, both for fresh 
and frozen cycles. In 2008, JSOG recommended restricting the num-
ber of ETs to one in order to prevent multiple pregnancies but double 
ET was allowed for women who are older than 35 years of age or 
for women who have experienced recurrent implantation failure. As 
a result, the number of single ETs has increased from 49.9% in 2007 
to 73.0% in 2010, while multiple pregnancies have decreased from 
11.5% in 2007 to 4.8% in 2010.6 The single ET policy has been cred-
ited with improving other indicators of perinatal outcomes in Japan.7
There was a significant increasing trend in the number of fresh cy-
cles with freeze- all embryos and oocytes (Table 1). Frozen- thawed ET 
TABLE  3 Characteristics and treatment outcomes of frozen 
cycles using assisted reproductive technology in Japan in 2015
Variable
Frozen- thawed 
embryo transfer Others Total
Total number of 
registered cycles
172 946 1563 174 509
Total number of FETs 169 898 1462 171 360
Number of cycles with 
a pregnancy
56 355 518 56 873
Pregnancy rate per 
embryo transfer
33.2% 35.4% 33.2%
SET cycles 139 027 1078 140 105
Pregnancy following 
SET cycles
47 582 377 47 959
Rate of SET cycles 81.8% 73.7% 81.8%
Pregnancy rate 
following SET
34.2% 35.0% 34.2%
Miscarriages 14 877 147 15 024
Miscarriage rate per 
pregnancy
26.4% 28.4% 26.4%
Singleton 
pregnanciesa
53 520 404 53 924
Multiple pregnancies 1770 33 1803
Twin pregnanciesa 1736 33 1769
Triplet pregnanciesa 33 0 33
Quadruplet 
pregnanciesa
1 0 1
Multiple pregnancy 
rate
3.2% 7.6% 3.2%
Live birth rate per 
embryo transfer
23.0% 23.1% 23.0%
Total number of 
neonates
40 242 357 40 599
Singleton live births 37 740 315 38 055
Twin live births 1233 21 1254
Triplet live births 12 0 12
Ectopic pregnancies 348 1 349
Intrauterine 
pregnancies 
coexisting with an 
ectopic pregnancy
6 6 12
Artificial abortions 219 0 219
Stillbirths 203 3 206
Fetal reductions 4 20 24
aSingleton, twin, triplet, and quaduplet pregnancies were defined accord-
ing to the number of gestational sacs in utero. SET, single embryo transfer.
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cycles reportedly result in better pregnancy and perinatal outcomes 
than fresh cycles,7-9 and recently, strategies for fresh cycles using 
freeze- all embryos has been suggested.10 In order to avoid the risk of 
ovarian hyperstimulation syndrome, fresh cycles with freeze- all em-
bryos probably will increase in the future.
The strengths of the ART registry system in Japan are its man-
datory reporting system and high compliance rate. Patients cannot 
receive a government subsidy for a cycle if their ART facility does 
not register the procedure. As almost all participating ART clinics and 
hospitals register cycle- specific information (99.3%), information on 
the latest clinical practices of ART in Japan are available. In contrast, 
the registry has several limitations. First, it includes multiple cycles 
for each patient over the years and it is impossible to distinguish cy-
cles for a given patient; therefore, the correlations within a single 
patient could bias the clinical outcomes. Second, the registration of 
cycle- specific information and pregnancy outcomes depends on each 
ART facility; therefore, standardization of the data registration is im-
portant. Although JSOG publishes frequently asked questions and 
answers about registering data online and periodically scrutinizes 
these data in order to maintain their integrity, assessing the validity 
of the registry will continue to be very important in the future.11,12
In conclusion, this analysis of the ART registry for 2015 demon-
strated that the total number of ART cycles increased and resulted in 
51 001 neonates (1 in 19.7 neonates who were born in Japan). The pa-
tients’ age when they received an ART procedure was higher than the 
mean age of primiparae in Japan. Single ET was performed at a rate of 
almost 80% and 96% of live births were singletons. The ET cycles have 
shifted from fresh to frozen cycles as fresh cycles with freeze- all em-
bryos have increased. These data represent the latest clinical practices 
of ART in Japan and the registry has greatly contributed to improving 
the success and safety of ART in Japan.
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TABLE  5 Treatment outcomes of embryo transfers using 
frozen- thawed oocytes and assisted reproductive technology in 
Japan in 2015
Variable
Embryo transfer using 
frozen- thawed oocytes
Total number of registered cycles 231
Total number of embryo transfers 135
Number of cycles with a pregnancy 15
Pregnancy rate per embryo transfer 11.1%
SET cycles 88
Pregnancy following SET cycles 10
Rate of SET cycles 65.2%
Pregnancy rate following SET 11.4%
Miscarriages 4
Miscarriage rate per pregnancy 26.7%
Singleton pregnanciesa 10
Multiple pregnancies 1
Twin pregnanciesa 1
Triplet pregnanciesa 0
Quadruplet pregnanciesa 0
Multiple pregnancy rate 9.1%
Live births 11
Live birth rate per embryo transfer 8.1%
Total number of neonates 12
Singleton live births 10
Twin live births 1
Triplet live births 0
Ectopic pregnancies 0
Intrauterine pregnancies coexisting 
with an ectopic pregnancy
0
Artificial abortions 0
Stillbirths 0
Fetal reduction 0
Unknown cycles for pregnancy 
outcomes
0
aSingleton, twin, triplet, and quadruplet pregnancies were defined ac-
cording to the number of gestational sacs in utero. SET, single embryo 
transfer.
F IGURE  2 Rates of pregnancy, 
live,births, and miscarriage by patient 
age in Japan in 2015, according to the 
assisted reproductive technology registry. 
Adapted from The Japan Society of 
Obstetrics and Gynecology ART Databook 
2015 (http://plaza.umin.ac.jp/~jsog-
art/2015data_201709.pdf) (in Japanese). 
ET, embryo transfer
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